US drug regulator âunsatisfiedâ by Philips’s progress on ventilator recall
HQ Team October 6, 2023: Dutch medical device maker, Philips Respironics, agreed to conduct further tests on its faulty ventilators after the USFDA.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team October 6, 2023: Dutch medical device maker, Philips Respironics, agreed to conduct further tests on its faulty ventilators after the USFDA.
HQ Team October 5, 2023: A new study by Columbia University Mailman School of Public Health and NYU Grossman School of Medicine says.
October 3, 2023: Limna Purushan, 46, works as a domestic helper in my home in Kochi. She has been saving up all her.
HQ Team October 2, 2023: Cordis, a US-based medical device maker, has acquired Switzerlandâs MedAlliance for up to $1.1 billion to expand its.
HQ Team September 27, 2023: India, the third-largest pharmaceutical industry in the world by volume, has unveiled a policy to make the South.
HQ Team September 26, 2023: Amazon is investing $4 billion to take up an unspecified minority stake in artificial intelligence systems company Anthropic..
HQ Team September 20, 2023: Elon Muskâs Neuralink Corp., got a nod from an independent institutional review board to start recruiting for a.
HQ Team September 20, 2023: Boston Scientific has acquired privately-held Relievant Medsystems, for more than $850 million to expand into the chronic low.
HQ Team Sept 14, 2023: Researchers at the University of Chicago’s Pritzker School of Molecular Engineering have developed an “inverse vaccine” to combat.
HQ Team September 12, 2023: The USFDA, in a bid to protect consumers, has issued warning letters to eight companies for marketing illegal.